Celyad Oncology SA (CLYYF)
Celyad Oncology Market Cap : 15.67M for April 8, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Galapagos NV | 1.882B |
| UCB SA | 60.56B |
| Ion Beam Applications SA | 462.09M |
| Fagron NV | 1.978B |
| AgomAb Therapeutics NV | 508.32M |
Market Cap Related Metrics
| PE Ratio | 11.71 |
| PS Ratio | 617.02 |
| Price to Book Value | 0.6728 |
| Price | 0.35 |
| Earnings Yield | 8.54% |
| Normalized PE Ratio | 11.71 |